학술논문
A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study.
Document Type
Article
Author
Fangusaro, Jason; Onar-Thomas, Arzu; Poussaint, Tina Young; Wu, Shengjie; Ligon, Azra H; Lindeman, Neal; Campagne, Olivia; Banerjee, Anu; Gururangan, Sridharan; Kilburn, Lindsay B; Goldman, Stewart; Qaddoumi, Ibrahim; Baxter, Patricia; Vezina, Gilbert; Bregman, Corey; Patay, Zoltan; Jones, Jeremy Y; Stewart, Clinton F; Fisher, Michael J; Doyle, Laurence Austin
Source
Neuro-Oncology; Oct2021, Vol. 23 Issue 10, p1777-1788, 12p
Subject
Language
ISSN
15228517